4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-18-047854
Director sold 30,000 shares at an average $59.96 ($1,798,800)
- Director acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| WINGER DENNIS L Director | 2018-08-17 | Option exercise | +15,000 | $14.26 | $213,900 | 57,750 | D: show line 1 in the form |
| WINGER DENNIS L Director | 2018-08-17 | Sale | −15,000 | $59.62 | $894,300 | 42,750 | D: show line 2 in the form |
| WINGER DENNIS L Director | 2018-08-21 | Option exercise | +15,000 | $14.26 | $213,900 | 57,750 | D: show line 3 in the form |
| WINGER DENNIS L Director | 2018-08-21 | Sale | −15,000 | $60.30 | $904,500 | 42,750 | D: show line 4 in the form |
| Open-market sales · 30,000 sh · avg $59.96 · $1,798,800 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| WINGER DENNIS L Director | 2018-08-17 | Option exercise · Stock Option | −15,000 | $14.26 | $213,900 | 15,000 | D: show line 5 in the form | |||
| WINGER DENNIS L Director | 2018-08-21 | Option exercise · Stock Option | −15,000 | $14.26 | $213,900 | 0 | D: show line 6 in the form |
Loading xslF345X03/doc4.xml…